Gofen & Glossberg’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Gofen & Glossberg’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,510	Closed	-$204K	–	623
2021 Q2	$204K	Hold	1,510	–	–	﹤0.01%	530
2021 Q1	$205K	Hold	1,510	–	–	0.01%	509
2020 Q4	$213K	Buy	+1,510	New	+$193K	0.01%	474

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Gofen & Glossberg's XBI Position: Q3 2021 in Review

Gofen & Glossberg sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 1,510 shares — an estimated $204K sold.

Gofen & Glossberg first reported a position in XBI in Q4 2020 and held it in 3 quarters. The position peaked at $213K in Q4 2020. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Gofen & Glossberg reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
Gofen & Glossberg sold 1,510 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $204K.
Gofen & Glossberg first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 3 quarters.
Gofen & Glossberg's State Street SPDR S&P Biotech ETF position peaked at $213K in Q4 2020.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Gofen & Glossberg's 13F filing for Q3 2021, filed 13 Oct 2021.